People with elevated amyloid levels in the brain but no signs of cognitive decline are indeed more likely to develop impairment down the road, potentially leading to full-on Alzheimer’s, according to a study published online June 12 in JAMA.

People taking sides in the mammography debates have a fresh controversy to feed on. This one has some Ivy League heft—and a pointed statement from the American College of Radiology—behind it.

WAYNE, NJ—(Marketwired - June 13, 2017)—At the upcoming 4th Annual World Congress of Thoracic Imaging (WCTI), Konica Minolta Healthcare will showcase advancements in an exciting technology under development, Dynamic Chest Radiography. This new modality utilizes Konica Minolta's Digital Flat Panel X-ray Detector and proprietary data analysis software that has the potential to allow clinicians to assess anatomical and physiological information simultaneously, data not previously available from a conventional X-ray. The commonly performed chest X-ray can now serve multiple functions, without subjecting the patient to multiple tests.

The best part of being a radiologist specializing in breast imaging is taking care of patients. The hardest part is telling some of them that they have cancer—but even then, you have the rewarding experience of supporting them “through the very difficult time surrounding a new cancer diagnosis” as they begin their treatment journey.

Amsterdam, the Netherlands and Denver, Colo.—Royal Philips (NSYE: PHG, AEX: PHIA) today announced that it will be showcasing molecular imaging solutions highlighting Philips’ commitment to innovation and more personalized care at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2017 Annual Meeting.

At one busy, academically affiliated breast center in the Northeast U.S., the so-called “Angelina Jolie Effect”—women being motivated by the celebrity to get screened for breast cancer—isn’t a thing.

At the 2017 annual meeting of the Society of Nuclear Medicine & Molecular Imaging (SNMMI), June 10-14 at Denver’s Colorado Convention Center, Siemens Healthineers debuts Symbia Intevo Bold¹, a system that combines the company’s proven single-photon emission computed tomography (SPECT) technologies with new, high-performance CT capabilities to enable a wide range of clinical applications.

Annual screening mammography adds no value to women who are high risk for breast cancer and, as a matter of course, are already getting screened each year with breast MRI, according to a study conducted at the University of Toronto and published online June 6 in Radiology.